Chicago, IL – Ellis Bio, a new biotech company spun out from The University of Chicago, officially launches this week with a mission to revolutionize epigenomics research. Founded by Professor Chuan ...
After Kalaris and AlloVir combine, the new company will have about $100 million to advance a treatment for age-related ...
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...
On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback